HEPION PHARMACEUTICALS, INC. Depreciation
HEPION PHARMACEUTICALS, INC. (HEPA) reported Depreciation of $100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-04-08
- HEPION PHARMACEUTICALS, INC. depreciation for the quarter ending 2024-12-31 was $69.24K, a 53.82% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. depreciation for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. depreciation for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. depreciation for the quarter ending 2024-03-31 was $30.76K, a 70.53% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $100.00K, a 0.00% change from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $100.00K, a 0.00% change from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
- HEPION PHARMACEUTICALS, INC. depreciation for fiscal 2021 was $100.00K, a 189.73% increase from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | $69.24K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $69.24K derived: sum of 2 quarters · filed 2025-04-08 | $69.24K derived: sum of 3 quarters · filed 2025-04-08 | $100.00K 10-K · filed 2025-04-08 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $30.76K 10-Q · filed 2024-11-14 | $75.77K derived: sum of 4 quarters · filed 2025-04-08 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $30.76K 10-Q · filed 2024-08-13 | $75.77K derived: sum of 3 quarters · filed 2025-04-08 | $94.27K derived: sum of 4 quarters · filed 2025-04-08 | ||
| 2024-03-31 | $30.76K 10-Q · filed 2024-05-21 | $75.77K derived: sum of 2 quarters · filed 2025-04-08 | $94.27K derived: sum of 3 quarters · filed 2025-04-08 | $112.60K derived: sum of 4 quarters · filed 2025-04-08 | ||
| 2023-12-31 | $45.02K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | $63.52K derived: sum of 2 quarters · filed 2025-04-08 | $81.84K derived: sum of 3 quarters · filed 2025-04-08 | $100.00K 10-K · filed 2025-04-08 | ||
| 2023-09-30 | $18.50K 10-Q · filed 2024-11-14 | $36.83K derived: sum of 2 quarters · filed 2024-11-14 | $54.98K 10-Q · filed 2024-11-14 | $54.87K 10-Q · filed 2023-11-20 | $95.88K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $18.33K 10-Q · filed 2024-08-13 | $36.37K 10-Q · filed 2024-08-13 | $77.38K derived: sum of 3 quarters · filed 2024-08-13 | $95.11K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $18.04K 10-Q · filed 2024-05-21 | $59.05K derived: sum of 2 quarters · filed 2024-05-21 | $76.78K derived: sum of 3 quarters · filed 2024-05-21 | $95.31K derived: sum of 4 quarters · filed 2024-05-21 | ||
| 2022-12-31 | $41.02K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $58.74K derived: sum of 2 quarters · filed 2024-04-16 | $77.27K derived: sum of 3 quarters · filed 2024-04-16 | $100.00K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $17.73K 10-Q · filed 2023-11-20 | $36.26K derived: sum of 2 quarters · filed 2023-11-20 | $58.98K 10-Q · filed 2023-11-20 | $96.33K derived: sum of 4 quarters · filed 2023-11-20 | ||
| 2022-06-30 | $18.53K 10-Q · filed 2023-08-14 | $41.26K 10-Q · filed 2023-08-14 | $41.26K 10-Q · filed 2022-08-15 | $78.60K derived: sum of 3 quarters · filed 2023-08-14 | $101.71K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $22.73K 10-Q · filed 2023-05-12 | $60.07K derived: sum of 2 quarters · filed 2023-05-12 | $83.18K derived: sum of 3 quarters · filed 2023-05-12 | $104.59K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $37.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $60.45K derived: sum of 2 quarters · filed 2023-04-10 | $81.86K derived: sum of 3 quarters · filed 2023-04-10 | $100.00K 10-K · filed 2023-04-10 | ||
| 2021-09-30 | $23.11K 10-Q · filed 2022-11-14 | $44.52K derived: sum of 2 quarters · filed 2022-11-14 | $62.66K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $21.41K 10-Q · filed 2022-08-15 | $39.55K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $18.14K 10-Q · filed 2022-05-16 | |||||
| 2020-12-31 | $34.52K 10-K · filed 2022-04-08 | |||||
| 2017-12-31 | $10.97K 10-KT · filed 2018-03-26 | |||||
| 2017-06-30 | $27.99K 10-KT · filed 2018-03-26 | |||||
| 2016-06-30 | $21.52K 10-KT · filed 2018-03-26 | |||||
| 2015-06-30 | $16.36K 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |